1. Home
  2. MIST vs DM Comparison

MIST vs DM Comparison

Compare MIST & DM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • DM
  • Stock Information
  • Founded
  • MIST 2003
  • DM 2015
  • Country
  • MIST Canada
  • DM United States
  • Employees
  • MIST N/A
  • DM N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • DM Industrial Machinery/Components
  • Sector
  • MIST Health Care
  • DM Technology
  • Exchange
  • MIST Nasdaq
  • DM Nasdaq
  • Market Cap
  • MIST 98.1M
  • DM 87.7M
  • IPO Year
  • MIST N/A
  • DM N/A
  • Fundamental
  • Price
  • MIST $0.88
  • DM $4.99
  • Analyst Decision
  • MIST Strong Buy
  • DM Hold
  • Analyst Count
  • MIST 2
  • DM 1
  • Target Price
  • MIST $17.00
  • DM $5.50
  • AVG Volume (30 Days)
  • MIST 4.5M
  • DM 3.4M
  • Earning Date
  • MIST 03-13-2025
  • DM 05-08-2025
  • Dividend Yield
  • MIST N/A
  • DM N/A
  • EPS Growth
  • MIST N/A
  • DM N/A
  • EPS
  • MIST N/A
  • DM N/A
  • Revenue
  • MIST N/A
  • DM $168,283,000.00
  • Revenue This Year
  • MIST N/A
  • DM N/A
  • Revenue Next Year
  • MIST $1,105.43
  • DM $6.25
  • P/E Ratio
  • MIST N/A
  • DM N/A
  • Revenue Growth
  • MIST N/A
  • DM N/A
  • 52 Week Low
  • MIST $0.75
  • DM $1.84
  • 52 Week High
  • MIST $2.75
  • DM $11.80
  • Technical
  • Relative Strength Index (RSI)
  • MIST 30.59
  • DM 81.39
  • Support Level
  • MIST $1.86
  • DM $2.18
  • Resistance Level
  • MIST $2.36
  • DM $2.79
  • Average True Range (ATR)
  • MIST 0.23
  • DM 0.29
  • MACD
  • MIST -0.06
  • DM 0.32
  • Stochastic Oscillator
  • MIST 7.43
  • DM 96.93

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About DM Desktop Metal Inc.

Desktop Metal Inc manufactures 3D printing to make metal and carbon fiber 3D printing accessible to all engineers, designers, and manufacturers. 3D metal printing helps in the design and development of automotive parts, consumer goods, manufacture of industrial equipment, and design of mechanical systems. The company ships its product to markets in the Americas, Europe Middle East and Africa (EMEA), and Asia Pacific (APAC). It derives maximum revenue from Americas.

Share on Social Networks: